Evidence map›Paper›PMID 16260599›Full record

ArticleMolecular and cellular biology2005

A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.

Jan Seyfried, Xin Wang, Giorgi Kharebava, Cathy Tournier

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Fine Mapping of theFrontiers in genetics · 2022
    Article
  3. Article
  4. Review
  5. Oncogenic signaling of MEK5-ERK5.Cancer letters · 2017
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. MEK5/ERK5 pathway: the first fifteen years.Biochimica et biophysica acta · 2012
    Review
  12. Article
  13. Article
  14. Article
  15. A retrograde neuronal survival response: target-derived neurotrophins regulate MEF2D and bcl-w.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
  16. Selectivity of docking sites in MAPK kinases.The Journal of biological chemistry · 2009
    Article
  17. Article
  18. Article
  19. MAP kinase pathways: the first twenty years.Biochimica et biophysica acta · 2007
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jan SeyfriedFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, United Kingdom.
Xin Wang
Giorgi Kharebava
Cathy Tournier
University of Manchester · GB

Funding

Medical Research Council G0001285
6 · The paper itself

Abstract

The alternative splicing of the mek5 gene gives rise to two isoforms. MEK5beta lacks an extended N terminus present in MEK5alpha. Comparison of their activities led us to identify a novel mitogen-activated protein kinase (MAPK) docking site in the N terminus of MEK5alpha that is distinct from the consensus motif identified in the other MAPK kinases. It consists of a cluster of acidic residues at position 61 and positions 63 to 66. The formation of the MEK5/extracellular signal-regulated kinase 5 (ERK5) complex is critical for MEK5 to activate ERK5, to increase transcription via MEF2, and to enhance cellular survival in response to osmotic stress. Certain mutations in the ERK5 docking site that prevent MEK5/ERK5 interaction also abrogate the ability of MEKK2 to bind and activate MEK5. However, the identification of MEK5alpha mutants with selective binding defect demonstrates that the MEK5/ERK5 interaction does not rely on the binding of MEK5alpha to MEKK2 via their respective PB1 domains. Altogether these results establish that the N terminus of MEK5alpha is critical for the specific organization of the components of the ERK5 signaling pathway.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCell SurvivalChlorocebus aethiopsCOS CellsEnzyme ActivationEpitopesFibroblastsGenes, ReporterGlutathione TransferaseImmunoblottingLuciferasesMADS Domain ProteinsMAP Kinase Kinase 5MAP Kinase Kinase Kinase 3EpitopesGlutathione TransferaseLuciferasesMADS Domain ProteinsMAP2K5 protein, humanMAP Kinase Kinase 5MAP Kinase Kinase Kinase 3MEF2A protein, humanMEF2 Transcription FactorsMitogen-Activated Protein Kinase 7Myogenic Regulatory FactorsProtein Isoforms

Identifiers

PMID16260599
PMCPMC1280269
OpenAlexW2096925894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.